Methylprednisolone and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Levocarnitine (levocarnitine). Common drug interactions include necrosis ischaemic among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Levocarnitine. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

On Jul, 15, 2026

33 people who take Methylprednisolone and Levocarnitine together, and have interactions are studied.

Methylprednisolone and Levocarnitine drug interactions.

What are the common drug interactions of Methylprednisolone and Levocarnitine, by gender? *:

female:

Necrosis ischaemic (death of cell due to lack of blood supply)
Sepsis (a severe blood infection that can lead to organ failure and death)
Drug ineffective
Infusion related reaction
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Hyperhidrosis (abnormally increased sweating)
Influenza
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Rash

male:

Alanine aminotransferase increased
Anaemia (lack of blood)
Asthenia (weakness)
Dyskinesia (abnormality or impairment of voluntary movement)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Hypotension (abnormally low blood pressure)
Hypotonia (low muscle tone)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Respiratory failure (inadequate gas exchange by the respiratory system)
Skin haemorrhage (bleeding into skin)

What are the common drug interactions of Methylprednisolone and Levocarnitine, by age (0-1 to 60+)? *:

0-1:

Asthenia (weakness)
Body temperature increased
Constipation
Decreased appetite
Dyskinesia (abnormality or impairment of voluntary movement)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Hypotonia (low muscle tone)
Labyrinthine fistula (an abnormal opening in the bony capsule of the inner ear)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Respiratory failure (inadequate gas exchange by the respiratory system)

2-9:

Necrosis ischaemic (death of cell due to lack of blood supply)
Sepsis (a severe blood infection that can lead to organ failure and death)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Hyperhidrosis (abnormally increased sweating)
Influenza
Infusion related reaction
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Rash
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

Hyperammonaemia
Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Crying
Discomfort
Drug intolerance (drug sensitivity)
Dyspnoea (difficult or laboured respiration)
Emotional disorder
Fatigue (feeling of tiredness)

20-29:

Abortion induced (medically referred abortion)
Drug ineffective
Maternal exposure during pregnancy (use of substance during pregnancy)

30-39:

Drug ineffective
Multiple-drug resistance

40-49:

Chest discomfort
Infusion related reaction
Liver injury
Platelet count decreased
Pyrexia (fever)

50-59:

Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Peripheral ischaemia (impaired circulation to an extremity)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Thrombocytopenia (decrease of platelets in blood)
Alanine aminotransferase increased
Anaemia (lack of blood)
Aspartate aminotransferase increased
Blood bilirubin increased
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pancreatitis (inflammation of pancreas)

60+:

Hypotension (abnormally low blood pressure)
Pain
Presyncope
Respiratory depression (respiration has a rate below 12 breaths)

What are the existing conditions these people have? *

Infection: 8 people, 24.24%
Sedation: 6 people, 18.18%
Liver Transplant Rejection (failure of liver transplant): 6 people, 18.18%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 9.09%
Nausea And Vomiting: 3 people, 9.09%
Nausea (feeling of having an urge to vomit): 3 people, 9.09%
High Blood Pressure: 3 people, 9.09%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 6.06%
Ammonia Increased: 2 people, 6.06%
Anaesthesia: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Levocarnitine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously